Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
Stepkowski
S M
SM
Department of Surgery, University of Texas Medical School, Houston 77030, USA.
Wang
M
M
Qu
X
X
Yu
J
J
Okamoto
M
M
Tejpal
N
N
Kahan
B D
BD
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D000068876:Fingolimod Hydrochloride; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011090:Polyenes / Q000627:therapeutic use*; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011915:Rats, Inbred BUF; D011920:Rats, Inbred WF; D020123:Sirolimus; D013110:Sphingosine / Q000031:analogs & derivatives; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011090:Polyenes; D011409:Propylene Glycols; D016572:Cyclosporine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D020123:Sirolimus